{"nct_id":"NCT00216697","title":"An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib Therapy","status":"COMPLETED","status_verified_date":"2010-04","start_date":"2005-03","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2006-10","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}